Importing third-party workflows into EPI2ME Labs![Matt Parker]()
With the release of EPI2ME Labs version 4.0.0 we are now able to run community developed Nextflow…
November 30, 2022
6 min
Published by Author 12
Director, Clinical Bioinformatics Software
I focus on bioinformatics workflows for clinical applications, ensuring our workflows meet relevant standards.
Expertise
Bioinformatics
Clinical Workflows
Social Media
Influenza Workflow![Matt Parker]()
We are pleased to offer a new workflow for the analysis of targeted Oxford Nanopore Technologies…
August 24, 2022
2 min
Mpox Workflow![Matt Parker]()
Mpox is a double-stranded DNA virus. There is an ongoing outbreak of clade II (formerly West African…
June 01, 2022
2 min
London is Calling EPI2ME Labs![Matt Parker]()
London Calling 2022 is now only a week away and we wanted to give you some pointers on how you can…
May 12, 2022
2 min
SARS-CoV-2 Midnight Scheme Update![Matt Parker]()
Introduction This blog post will explain the changes we are making to the primer scheme naming in…
April 15, 2022
3 min
SARS-CoV-2 Midnight Analysis![Matt Parker]()
Introduction I wanted to write a blog post about SARS-CoV-2 sequencing data analysis to achieve two…
January 24, 2022
6 min
Page 2 of 2
Information
© 2020 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.